Johannes Holzmeister is an internationally recognized cardiologist and is the Co-Founder, Chairman and Chief Executive Officer at DiNAQOR.
Dr. Holzmeister has more than two decades of clinical research experience. He was an attending physician at Charité, one of Europe’s largest teaching hospitals and one of Germany’s top medical research institutions. He also worked at the University Hospital of Zürich, where he led the interventional device group for heart failure patients.
In 2010, Dr. Holzmeister founded and served as CEO of Cardiorentis, a biopharmaceutical company offering a technology platform integrating expertise in protein biology to identify novel targets and design small molecule compounds and peptides for healthcare markets, including in the areas of heart failure and other cardiovascular diseases.
Dr. Holzmeister’s research has been published in leading medical journals including The New England Journal of Medicine and The Lancet. He received his MD from Humboldt University of Berlin.